Smart Insulin Pens Market by Type - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4403189
  • Report
  • Region: Global
  • 120 pages
  • Allied Analytics LLP
1 of 3
Smart insulin pen is a medical device used to inject insulin for the treatment of diabetes. Insulin pens have an attached insulin cartridge and hence do not need a syringe and separate vial.
The global smart insulin pens market was valued at $57 million in 2016, and is estimated to reach $117 million by 2023, growing at a CAGR of 10.7% from 2017 to 2023. The market is expected to witness significant growth during the forecast period owing to rising geriatric population coupled with increasing incidence of diabetics. In addition, these pens can be easily used by people with visual or fine motor skills impairments further stimulates the market growth. However, insulin pens are inconvenient to use for the patients in need of mixture of two type of insulins, which in turn impedes the market growth.

The global smart insulin pens market is segmented on the basis of type, usability, end user, and region. Based on type, the market is classified into first generation and second generation insulin pens. The second generation insulin pens are further bifurcated into Bluetooth-enabled and USB-connected insulin pens. By usability, it is segmented into pre-filled and reusable insulin pumps. According to the end user, the market is classified into hospitals & clinics, ambulatory surgical centers, and home care settings. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The global smart insulin pens market is highly competitive and is lucrative in nature. The key market players have adopted various developmental strategies such as product launch & approval, strategic acquisitions, and mergers to strengthen their market position.

KEY BENEFITS FOR STAKEHOLDERS

The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors.
It offers an extensive analysis of the current and emerging market trends and dynamics through 2016–2023 to identify the upcoming market opportunities.
Recent industry trends and developments and the future opportunities are also covered.
Extensive knowledge about the key market players and their strategies is provided.
Comprehensive analysis of factors that drive and restrain the growth of the market is provided.

KEY MARKET SEGMENTS

By Type

First Generation Pens
Second Generation Pens
Bluetooth Enabled
USB Connected

By Usability

Prefilled
Reusable

By End User

Hospitals & Clinics
Ambulatory Surgical Centers
Home Care Settings

By Region

North America
U.S.
Canada
Mexico
Europe
France
Germany
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa

Key market players

The key players operating in this market include the following:
Eli Lilly and Company
Novo Nordisk
Companion Medical
DIAMESCO
Emperra GmbH
READ MORE
Note: Product cover images may vary from those shown
2 of 3
CHAPTER 1 INTRODUCTION

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top wining strategies

3.2.1.1. Competitive intelligence of companies and their strategies

3.2.2. Top investment pockets

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Increasing incidence of diabetes
3.3.1.2. Rising geriatric population
3.3.1.3. Technological advancements

3.3.2. Restrains

3.3.2.1. Not suitable for combination insulin

3.3.3. Opportunities

3.3.3.1. Untapped opportunities in emerging nations

3.3.4. Impact analysis

3.4. MARKET SHARE ANALYSIS, 2016
3.5. GOVERNMENT REGULATIONS
3.6. CLINICAL TRIALS

CHAPTER 4 SMART INSULIN PENS MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. FIRST GENERATION PENS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. SECOND GENERATION PENS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Bluetooth-enabled pens

4.3.4.1. Market size and forecast

4.3.5. USB connected pens

4.3.5.1. Market size and forecast

CHAPTER 5 SMART INSULIN PENS MARKET, BY USABILITY

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. PRE-FILLED PENS

5.2.1. Market size and forecast

5.3. REUSABLE PENS

5.3.1. Market size and forecast

CHAPTER 6 SMART INSULIN PENS MARKET, BY END-USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS & CLINICS

6.2.1. Market size and forecast

6.3. AMBULATORY SURGICAL CENTERS

6.3.1. Market size and forecast

6.4. HOME CARE SETTINGS

6.4.1. Market size and forecast

CHAPTER 7 SMART INSULIN PENS MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Growth factors and opportunities
7.2.3. Market size and forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Growth factors and opportunities
7.3.3. Market size and forecast

7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Growth factors and opportunities
7.4.3. Market size and forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. India market size and forecast
7.4.3.4. Australia market size and forecast
7.4.3.5. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Growth factors and opportunities
7.5.3. Market size and forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. South Africa market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1. ELI LILLY AND COMPANY

8.1.1. Company overview
8.1.2. Operating business segments
8.1.3. Business performance
8.1.4. Key strategic moves and developments

8.2. NOVO NORDISK

8.2.1. Company overview
8.2.2. Operating business segments
8.2.3. Business performance
8.2.4. Key strategic moves and developments

8.3. COMPANION MEDICAL

8.3.1. Company overview
8.3.2. Operating business segments
8.3.3. Business performance
8.3.4. Key strategic moves and developments

8.4. DIAMESCO

8.4.1. Company overview
8.4.2. Operating business segments
8.4.3. Business performance
8.4.4. Key strategic moves and developments

8.5. EMPERRA GMBH

8.5.1. Company overview
8.5.2. Operating business segments
8.5.3. Business performance
8.5.4. Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll